Clearstead Trust’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355 Sell
12
-20
-63% -$513 ﹤0.01% 959
2026
Q1
$749 Buy
+32
New +$579 ﹤0.01% 951
2025
Q4
Sell
-91
Closed -$2.25K 1006
2025
Q3
$2.25K Sell
91
-5
-5% -$112 ﹤0.01% 958
2025
Q2
$2.18K Buy
96
+48
+100% +$1.14K ﹤0.01% 923
2025
Q1
$1.46K Buy
+48
New +$1.83K ﹤0.01% 800
2023
Q4
Sell
-64
Closed -$4.5K 414
2023
Q3
$4.5K Buy
+64
New +$4.78K ﹤0.01% 386

Other funds holding ACHC

Clearstead Trust's ACHC Position: Q2 2026 in Review

Clearstead Trust reduced its Acadia Healthcare (ACHC) stake by 63% in Q2 2026, selling an estimated $513 and leaving 12 shares worth $355. The position accounts for ﹤0.01% of the portfolio, ranked #959.

Clearstead Trust first reported a position in ACHC in Q3 2023 and has held it in 6 quarters since. The position peaked at $4.5K in Q3 2023. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Clearstead Trust held 12 shares of Acadia Healthcare worth $355 as of Q2 2026.
  • Clearstead Trust sold 20 Acadia Healthcare shares in Q2 2026, an estimated $513.
  • Acadia Healthcare made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #959 holding.
  • Clearstead Trust first reported a position in Acadia Healthcare in Q3 2023 and has held it in 6 quarters since.
  • Clearstead Trust's Acadia Healthcare position peaked at $4.5K in Q3 2023.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.